13F filer · CIK 1697748 ↗
ARK Invest
You are looking at Q4 2020. See the latest, Q2 2026 →
Reported value
$37.59B
+123% on the quarter before
Positions
244
27 new · 6 sold out
Top 10
36.9%
of the value
Est. gain
+$6.14B
on stocks held all quarter
Est. return
+39.1%
on those stocks since Q3 2020
Positions as of Dec 31, 2020, from ARK Invest's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
The 24 largest positions, 59% of the reported value, each sized by its share, colored by what the fund did with it since Q3 2020. Striped tiles are options.
Largest buys
Since Q3 2020, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Teladoc Health Inc~$1.16BAdded · 2.6% → 4.2%+5,819,546 shares
- Exact Sciences Corp~$633.7MAdded · 0.3% → 1.9%+4,783,270 shares
- PayPal~$552.6MAdded · 0.3% → 1.6%+2,359,532 shares
- Shopify Inc~$544.4MAdded · 0.0% → 1.4%+480,913 shares
- Tesla~$496.4MAdded · 8.7% → 7.8%+703,448 shares
- Roku Inc~$472.2MAdded · 4.4% → 4.7%+1,422,211 shares
- Baidu~$468.4MAdded · 0.1% → 1.3%+2,166,239 shares
- Ke Holdings Inc~$408.5MNew · 0.0% → 1.1%+6,638,093 shares
- Spotify Technology Sa~$387.7MAdded · 1.6% → 2.0%+1,232,270 shares
- Twist Bioscience Corp~$383.8MAdded · 1.4% → 2.2%+2,716,493 shares
Largest sells
Since Q3 2020, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Slack Technologies Inc~$546.5MCut · 2.2% → 0.1%−12,937,970 shares
- Illumina Inc~$343.4MCut · 1.8% → 0.0%−928,078 shares
- Xilinx Inc~$232.9MCut · 1.1% → 0.1%−1,642,899 shares
- Zscaler~$196.0MCut · 0.9% → 0.0%−981,482 shares
- Editas Medicine Inc~$38.2MCut · 1.8% → 1.9%−544,860 shares
- Invitae Corp~$31.5MCut · 7.1% → 3.0%−753,601 shares
- Twitter Inc~$29.6MSold out · 0.2% → 0.0%−665,508 shares
- Syros Pharmaceuticals Inc~$23.6MCut · 0.6% → 0.3%−2,171,185 shares
- Meta~$20.6MCut · 1.1% → 0.5%−75,462 shares
- Exone Co/The~$16.0MCut · 0.3% → 0.1%−1,687,646 shares
Holdings
As of Dec 31, 2020. Changes are in shares against Sep 30, 2020, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| TeslaCommon Stock · shares +21% · price +64.5% | 7.8% | $2.92B | +$949.2M | ||||||||
| Roku IncCommon Stock · shares +36% · price +75.9% | 4.7% | $1.79B | +$566.4M | ||||||||
| Crispr Therapeutics AgCommon Stock · shares +23% · price +83.1% | 4.2% | $1.59B | +$587.5M | ||||||||
| Teladoc Health IncCommon Stock · shares +289% · price −8.8% | 4.2% | $1.57B | −$38.8M | ||||||||
| BlockCommon Stock · shares +21% · price +33.9% | 4.1% | $1.54B | +$321.2M | ||||||||
| Invitae CorpCommon Stock · shares −2.7% · price −3.6% | 3.0% | $1.13B | −$41.6M | ||||||||
| EverpureCommon Stock · shares +61% · price +46.9% | 2.5% | $930.7M | +$184.8M | ||||||||
| Zillow Group IncCommon Stock · shares +32% · price +27.8% | 2.2% | $841.3M | +$138.3M | ||||||||
| Twist Bioscience CorpCommon Stock · shares +86% · price +86.0% | 2.2% | $830.4M | +$206.4M | ||||||||
| Spotify Technology SaCommon Stock · shares +110% · price +29.7% | 2.0% | $741.4M | +$81.0M | ||||||||
| Pacific Biosciences Of CaliforCommon Stock · shares +44% · price +162.8% | 2.0% | $739.4M | +$318.9M | ||||||||
| Editas Medicine IncCommon Stock · shares −5.1% · price +149.9% | 1.9% | $709.9M | +$425.8M | ||||||||
| Iovance Biotherapeutics IncCommon Stock · shares +94% · price +40.9% | 1.9% | $709.8M | +$106.5M | ||||||||
| Exact Sciences CorpCommon Stock · shares +904% · price +30.0% | 1.9% | $703.8M | +$16.2M | ||||||||
| Proto Labs IncCommon Stock · shares +33% · price +18.5% | 1.7% | $632.0M | +$73.9M | ||||||||
| Intellia Therapeutics IncCommon Stock · shares −1.9% · price +173.6% | 1.6% | $608.8M | +$386.3M | ||||||||
| TwilioCommon Stock · shares +107% · price +37.0% | 1.6% | $607.2M | +$79.2M | ||||||||
| PayPalCommon Stock · shares +1,048% · price +18.9% | 1.6% | $605.3M | +$8.4M | ||||||||
| Lendingtree IncCommon Stock · shares +49% · price −10.8% | 1.5% | $550.4M | −$44.6M | ||||||||
| Shopify IncCommon Stock · shares +255,805% · price +10.8% | 1.4% | $544.6M | +$20,806 | ||||||||
| 2u IncCommon Stock · shares +0.2% · price +18.2% | 1.4% | $530.6M | +$81.4M | ||||||||
| Intercontinental Exchange IncCommon Stock · shares +216% · price +15.2% | 1.4% | $525.5M | +$22.0M | ||||||||
| TSMCADR · shares +72% · price +34.5% | 1.3% | $491.5M | +$73.2M | ||||||||
| BaiduADR · shares +2,291% · price +70.8% | 1.3% | $488.9M | +$8.5M | ||||||||
| DocuSignCommon Stock · shares +190% · price +3.3% | 1.3% | $484.6M | +$5.3M | ||||||||
| Total · 244 positions | 100% | $37.59B | +$6.14B |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q3 2020 to Q4 2020: 217 stocks held throughout, up $6.14B (+39.1%).
- Tesla+$949.2M+64%
- Crispr Therapeutics Ag+$587.5M+83%
- Roku Inc+$566.4M+76%
- Editas Medicine Inc+$425.8M+150%
- Intellia Therapeutics Inc+$386.3M+174%
- Teladoc Health Inc−$38.8M−9%
- Invitae Corp−$41.6M−4%
- Lendingtree Inc−$44.6M−11%
- Seres Therapeutics Inc−$46.8M−13%
- Compugen Ltd−$70.7M−25%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 14, 2026 | $15.40B+20% | SEC ↗ |
| Q1 2026 | May 12, 2026 | $12.86B−15% | SEC ↗ |
| Q4 2025 | Feb 11, 2026 | $15.07B−10% | SEC ↗ |
| Q3 2025 | Nov 12, 2025 | $16.80B+23% | SEC ↗ |
| Q2 2025 | Jul 30, 2025 | $13.64B+37% | SEC ↗ |
| Q1 2025 | May 7, 2025 | $9.99B−17% | SEC ↗ |
| Q4 2024 | Feb 4, 2025 | $12.01B+10% | SEC ↗ |
| Q3 2024 | Oct 31, 2024 | $10.93B−3% | SEC ↗ |
| Q2 2024 | Jul 26, 2024 | $11.27B−22% | SEC ↗ |
| Q1 2024 | Apr 18, 2024 | $14.44B−14% | SEC ↗ |
| Q4 2023 | Jan 17, 2024 | $16.89B+29% | SEC ↗ |
| Q3 2023 | Oct 18, 2023 | $13.07B−13% | SEC ↗ |
| Q2 2023 | Jul 10, 2023 | $15.10B+4% | SEC ↗ |
| Q1 2023 | Apr 17, 2023 | $14.55B+26% | SEC ↗ |
| Q4 2022 | Jan 24, 2023 | $11.54B−20% | SEC ↗ |
| Q3 2022 | Oct 17, 2022 | $14.35B−15% | SEC ↗ |
| Q2 2022 | Jul 11, 2022 | $16.91B−29% | SEC ↗ |
| Q1 2022 | Apr 18, 2022 | $23.96B−28% | SEC ↗ |
| Q4 2021 | Jan 28, 2022 | $33.08B−21% | SEC ↗ |
| Q3 2021 | Nov 12, 2021 | $41.64B−23% | SEC ↗ |
| Q2 2021 | Aug 5, 2021 | $53.74B+7% | SEC ↗ |
| Q1 2021 | May 13, 2021 | $50.34B+34% | SEC ↗ |
| Q4 2020 | Feb 12, 2021 | $37.59B+123% | SEC ↗ |
| Q3 2020 | Oct 30, 2020 | $16.86B+81% | SEC ↗ |
| Q2 2020 | Aug 11, 2020 | $9.30B+132% | SEC ↗ |
| Q1 2020 | May 14, 2020 | $4.01B+1% | SEC ↗ |
| Q4 2019 | Jan 31, 2020 | $3.96B−13% | SEC ↗ |
| Q3 2019 | Nov 12, 2019 | $4.58B+15% | SEC ↗ |
| Q2 2019 | Jul 30, 2019 | $3.97B+13% | SEC ↗ |
| Q1 2019 | May 13, 2019 | $3.50B+42% | SEC ↗ |
| Q4 2018 | Feb 11, 2019 (amended) | $2.46B−26% | SEC ↗ |
| Q3 2018 | Nov 7, 2018 | $3.31B+21% | SEC ↗ |
| Q2 2018 | Aug 7, 2018 | $2.73B+36% | SEC ↗ |
| Q1 2018 | May 14, 2018 | $2.01B+60% | SEC ↗ |
| Q4 2017 | Feb 12, 2018 | $1.26B+53% | SEC ↗ |
| Q3 2017 | Nov 9, 2017 | $819.3M+60% | SEC ↗ |
| Q2 2017 | Aug 11, 2017 | $513.6M+48% | SEC ↗ |
| Q1 2017 | May 15, 2017 | $346.9M+26% | SEC ↗ |
| Q4 2016 | Feb 13, 2017 | $274.9M | SEC ↗ |